Stock Price
181.70
Daily Change
3.59 2.02%
Monthly
5.36%
Yearly
-32.79%
Q1 Forecast
177.74

CSL reported $1.96B in EBITDA for its fiscal semester ending in June of 2025.





Ebitda Change Date
aTyr Pharma USD -26.58M 26.32M Sep/2025
CSL USD 1.96B 1.27B Jun/2025